These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30824523)

  • 41. Liquid biopsy in colon cancer: comparison of different circulating DNA extraction systems following absolute quantification of
    Kloten V; Rüchel N; Brüchle NO; Gasthaus J; Freudenmacher N; Steib F; Mijnes J; Eschenbruch J; Binnebösel M; Knüchel R; Dahl E
    Oncotarget; 2017 Oct; 8(49):86253-86263. PubMed ID: 29156792
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Using circulating cell-free DNA to monitor personalized cancer therapy.
    Oellerich M; Schütz E; Beck J; Kanzow P; Plowman PN; Weiss GJ; Walson PD
    Crit Rev Clin Lab Sci; 2017 May; 54(3):205-218. PubMed ID: 28393575
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Concordance of Mutation Detection in Circulating Tumor DNA in Early Clinical Trials Using Different Blood Collection Protocols.
    Ahlborn LB; Madsen M; Jonson L; Nielsen FC; Lassen U; Yde CW; Mau-Sorensen M
    Clin Lab; 2017 Oct; 63(10):1755-1759. PubMed ID: 29035458
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based ctDNA Assays: A Joint Consensus Recommendation of the BloodPAC's Analytical Variables Working Group.
    Godsey JH; Silvestro A; Barrett JC; Bramlett K; Chudova D; Deras I; Dickey J; Hicks J; Johann DJ; Leary R; Lee JSH; McMullen J; McShane L; Nakamura K; Richardson AO; Ryder M; Simmons J; Tanzella K; Yee L; Leiman LC
    Clin Chem; 2020 Sep; 66(9):1156-1166. PubMed ID: 32870995
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of circulating tumor DNA (ctDNA) by digital droplet polymerase chain reaction (dd-PCR) in liquid biopsies.
    Valpione S; Campana L
    Methods Enzymol; 2019; 629():1-15. PubMed ID: 31727235
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of plasma processing on recovery and analysis of circulating nucleic acids.
    Page K; Guttery DS; Zahra N; Primrose L; Elshaw SR; Pringle JH; Blighe K; Marchese SD; Hills A; Woodley L; Stebbing J; Coombes RC; Shaw JA
    PLoS One; 2013; 8(10):e77963. PubMed ID: 24205045
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development and clinical validation of a circulating tumor DNA test for the identification of clinically actionable mutations in nonsmall cell lung cancer.
    Liu L; Liu H; Shao D; Liu Z; Wang J; Deng Q; Tang H; Yang H; Zhang Y; Qiu Y; Cui F; Tan M; Zhang P; Li Z; Liu J; Liang W; Wang Y; Peng Z; Wang J; Yang H; Mao M; Kristiansen K; Ye M; He J
    Genes Chromosomes Cancer; 2018 Apr; 57(4):211-220. PubMed ID: 29277949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood.
    Kresse SH; Brandt-Winge S; Pharo H; Flatin BTB; Jeanmougin M; Vedeld HM; Lind GE
    Clin Epigenetics; 2023 Sep; 15(1):151. PubMed ID: 37710283
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel method for liquid-phase extraction of cell-free DNA for detection of circulating tumor DNA.
    Janku F; Huang HJ; Pereira DY; Kobayashi M; Chiu CH; Call SG; Woodbury KT; Chao F; Marshak DR; Chiu RYT
    Sci Rep; 2021 Oct; 11(1):19653. PubMed ID: 34608196
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients.
    Zill OA; Banks KC; Fairclough SR; Mortimer SA; Vowles JV; Mokhtari R; Gandara DR; Mack PC; Odegaard JI; Nagy RJ; Baca AM; Eltoukhy H; Chudova DI; Lanman RB; Talasaz A
    Clin Cancer Res; 2018 Aug; 24(15):3528-3538. PubMed ID: 29776953
    [No Abstract]   [Full Text] [Related]  

  • 51. Assessing HER2 Amplification in Plasma cfDNA.
    Garcia-Murillas I; Turner NC
    Methods Mol Biol; 2018; 1768():161-172. PubMed ID: 29717443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer.
    Sonpavde G; Agarwal N; Pond GR; Nagy RJ; Nussenzveig RH; Hahn AW; Sartor O; Gourdin TS; Nandagopal L; Ledet EM; Naik G; Armstrong AJ; Wang J; Bilen MA; Gupta S; Grivas P; Pal SK; Lanman RB; Talasaz A; Lilly MB
    Cancer; 2019 May; 125(9):1459-1469. PubMed ID: 30620391
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of tumor-derived extracellular vesicles in plasma from patients with solid cancer.
    Vitale SR; Helmijr JA; Gerritsen M; Coban H; van Dessel LF; Beije N; van der Vlugt-Daane M; Vigneri P; Sieuwerts AM; Dits N; van Royen ME; Jenster G; Sleijfer S; Lolkema M; Martens JWM; Jansen MPHM
    BMC Cancer; 2021 Mar; 21(1):315. PubMed ID: 33761899
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circulating tumoral DNA: Preanalytical validation and quality control in a diagnostic laboratory.
    Nikolaev S; Lemmens L; Koessler T; Blouin JL; Nouspikel T
    Anal Biochem; 2018 Feb; 542():34-39. PubMed ID: 29137972
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond.
    Keller L; Belloum Y; Wikman H; Pantel K
    Br J Cancer; 2021 Jan; 124(2):345-358. PubMed ID: 32968207
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Opportunities, Challenges, and Prospects in Electrochemical Biosensing of Circulating Tumor DNA and its Specific Features.
    Campuzano S; Serafín V; Gamella M; Pedrero M; Yáñez-Sedeño P; Pingarrón JM
    Sensors (Basel); 2019 Aug; 19(17):. PubMed ID: 31480367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial.
    Jovelet C; Ileana E; Le Deley MC; Motté N; Rosellini S; Romero A; Lefebvre C; Pedrero M; Pata-Merci N; Droin N; Deloger M; Massard C; Hollebecque A; Ferté C; Boichard A; Postel-Vinay S; Ngo-Camus M; De Baere T; Vielh P; Scoazec JY; Vassal G; Eggermont A; André F; Soria JC; Lacroix L
    Clin Cancer Res; 2016 Jun; 22(12):2960-8. PubMed ID: 26758560
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of surgical trauma on circulating free DNA levels in cancer patients-implications for studies of circulating tumor DNA.
    Henriksen TV; Reinert T; Christensen E; Sethi H; Birkenkamp-Demtröder K; Gögenur M; Gögenur I; Zimmermann BG; ; Dyrskjøt L; Andersen CL
    Mol Oncol; 2020 Aug; 14(8):1670-1679. PubMed ID: 32471011
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Establishing PNB-qPCR for quantifying minimal ctDNA concentrations during tumour resection.
    Ehlert T; Tug S; Brahmer A; Neef V; Heid F; Werner C; Jansen-Winkeln B; Kneist W; Lang H; Gockel I; Simon P
    Sci Rep; 2017 Aug; 7(1):8876. PubMed ID: 28827745
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review.
    Vymetalkova V; Cervena K; Bartu L; Vodicka P
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.